LAS VEGAS — At the Eyecelerator@ASCRS meeting, Richard Small, CPA, CEO of Neurotech Pharmaceuticals, offers a comprehensive update on the company’s current pipeline.
Uncategorized
VIDEO: Neurotech Pharmaceuticals summarizes clinical pipeline